Our data show that intake of a phosphate-rich diet results in inflammation-induced hypoferremia and ineffective erythropoiesis leading to anemia through the actions of elevated FGF23 on erythroid progenitors, in the absence of hyperphosphatemia and despite increased EPO secretion. The gene discussed is FGF23; the disease is hyperphosphatemia.